Trial Profile
A phase 2 pivotal, multi-center efficacy trial of AER-271 for the prevention of cerebral edema in severe ischemic stroke patients with Large Hemispheric Infarction (LHI)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2020
Price :
$35
*
At a glance
- Drugs AER-271 (Primary)
- Indications Brain oedema
- Focus Proof of concept; Registrational; Therapeutic Use
- Sponsors Aeromics
- 07 Jan 2020 According to an AEROMICS media release, this trial is expected to begin this year.
- 26 Jul 2018 New trial record